Helth & tips, &; Technology tips: India Rejects J&J Plea to Extend Patent on Key Tuberculosis Drug, Drop in Prices Expected

Thursday, March 23, 2023

India Rejects J&J Plea to Extend Patent on Key Tuberculosis Drug, Drop in Prices Expected

The patent on the drug made India dependent on supplies from J&J. The latest decision will pave the way for generic versions in the local market, increasing access

from Top India News- News18.com https://ift.tt/DX3xKsI

Labels:

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home